BACKGROUND: Long-term survival in lung transplant is limited by @entity4154 ( @entity4154 ). We compared outcomes in pediatric living donor bilateral lobar (LL) vs @entity358 ( @entity358 ). METHODS: @entity1 were studied who had LL or @entity358 with at least 1 year follow-up. Data collected included acute rejection episodes, pulmonary function tests (PFT), @entity4154 , and survival. Mean age was 13.36+/-3.16 years in LL and 12.00+/-4.19 years in @entity358 @entity1 (p = 0.37, ns). RESULTS: There was no difference in rejection (p = 0.41, ns). @entity358 had rejection earlier (2.48+/-3.84 months) than LL (13.60+/-10.74 months; p = 0.02). There was no difference in 12 month PFT. But at 24 months, LL had greater forced expiratory volume in 1 second (FEV1) (p = 0.001) and FEF25-71% (p = 0.01) than @entity358 . @entity4154 was found in 0/14 LL vs 9/11 (82%) @entity358 after 1 year (p = 0.04). After 2 years, 0/8 LL and 6/7 (86%) @entity358 had @entity4154 (p < 0.05). LL had 85% survival vs 79% for @entity358 at 12 months. At 24 months, LL survival was 77% vs 67% for @entity358 . CONCLUSIONS: Pediatric LL had less @entity4154 and better pulmonary function than @entity358 . As @entity4154 is a determinant of long-term outcome, we believe LL is the preferred lung transplant method for @entity1 .

Comparison of outcomes between living donor and cadaveric lung transplantation in XXXX .

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'Children'] @entity4154 :: ('MESH:D001989', 'Disease') :: ['bronchiolitis obliterans', 'BOS'] @entity358 :: ('MESH:D008171', 'Disease') :: ['CL', 'cadaveric lung transplant']
@entity1 :: (9606,Species) :: ['children']
